Trial · NCT03033108
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Electrical Response of the Retina to a Flash of Light, as Measured by Electroretinogram | Emixustat Dose 1 | -12.23 | Full Range -41.0 to 54.7 | percent suppression | |
| Change in Electrical Response of the Retina to a Flash of Light, as Measured by Electroretinogram | Emixustat Dose 2 | 68.00 | Full Range 1.0 to 91.5 | percent suppression | |
| Change in Electrical Response of the Retina to a Flash of Light, as Measured by Electroretinogram | Emixustat Dose 3 | 96.69 | Full Range 64.9 to 100.0 | percent suppression | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 1 | Subjects with 1 or more adverse events | 6 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 2 | Subjects with 1 or more adverse events | 8 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 3 | Subjects with 1 or more adverse events | 6 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 1 | Subjects with 1 or more mild adverse events | 5 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 2 | Subjects with 1 or more mild adverse events | 5 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 3 | Subjects with 1 or more mild adverse events | 4 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 1 | Subjects with 1 or more moderate adverse events | 1 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 2 | Subjects with 1 or more moderate adverse events | 2 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 3 | Subjects with 1 or more moderate adverse events | 2 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 1 | Subjects with 1 or more severe adverse events | 0 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 2 | Subjects with 1 or more severe adverse events | 1 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 3 | Subjects with 1 or more severe adverse events | 1 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 1 | Subjects with 1 or more serious adverse events | 0 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 2 | Subjects with 1 or more serious adverse events | 0 | Participants | |
| Percentage of Subjects With Adverse Events, by Severity and Seriousness | Emixustat Dose 3 | Subjects with 1 or more serious adverse events | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03033108/results